Home › Funds › Redmile Group, LLC › PLRX
Redmile Group, LLC position in PLRX
PLIANT THERAPEUTICS INC · Health Care
Redmile Group, LLC reported holding 772,126 shares of PLRX (PLIANT THERAPEUTICS INC) in its Q2 2026 13F filing — a position valued at US$880K, representing 0.06% of its reported portfolio and ranking #39 among its reported holdings. Redmile Group, LLC has disclosed PLRX holdings in 12 of the last 12 reported quarters, going back to Q3 2023.
Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR
How Redmile Group, LLC's PLRX position evolved
Redmile Group, LLC first disclosed a stake in PLRX in Q3 2023 at 2,678,099 shares (US$46.4M). The position peaked in Q4 2023 at 2,696,648 shares, worth US$48.8M. Across 12 filings, Redmile Group, LLC increased the stake 4 time(s), trimmed it 5 time(s) and left it unchanged 2 time(s). The most recent filing (Q2 2026) shows 772,126 shares valued at US$880K. Notable position changes include a 29% trim in Q1 2025 (shares fell 14% over the following quarter), a 52% trim in Q1 2026 (shares fell 10% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2023 | 2.68M | $46.44M | New |
| Q4 2023 | 2.70M | $48.84M | Add |
| Q1 2024 | 3.10M | $46.15M | Add |
| Q2 2024 | 3.21M | $34.50M | Add |
| Q3 2024 | 3.20M | $35.84M | Hold |
| Q4 2024 | 2.90M | $38.13M | Reduce |
| Q1 2025 | 2.05M | $2.77M | Reduce |
| Q2 2025 | 1.63M | $1.89M | Reduce |
| Q3 2025 | 1.59M | $2.36M | Reduce |
| Q4 2025 | 1.62M | $1.97M | Add |
| Q1 2026 | 772.13K | $972.88K | Reduce |
| Q2 2026 | 772.13K | $880.22K | Hold |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About PLRX and 13F data
PLRX (PLIANT THERAPEUTICS INC) is a Health Care company. 8 other funds we track also report a position in PLRX — the largest reported positions include TANG CAPITAL MANAGEMENT LLC (US$7.0M), Monaco Asset Management SAM (US$2.2M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding PLRX
- TANG CAPITAL MANAGEMENT LLC 6.14M sh · $7.00M · Q2 2026
- Monaco Asset Management SAM 1.94M sh · $2.21M · Q2 2026
More on Redmile Group, LLC
FAQ
How long has Redmile Group, LLC held PLRX?
Redmile Group, LLC has disclosed PLRX holdings in 12 of the last 12 reported quarters, going back to Q3 2023.
What is Redmile Group, LLC's current position in PLRX?
As of Q2 2026, Redmile Group, LLC holds 772.13K shares of PLRX (PLIANT THERAPEUTICS INC), valued at $880.22K, representing 0.06% of its reported portfolio and ranking #39.
Has Redmile Group, LLC been buying or selling PLRX?
In the latest 13F filing (Q2 2026), Redmile Group, LLC held unchanged its position in PLRX. The position peaked in Q4 2023 at 2.70M shares.
Which other funds hold PLRX?
Other major institutional holders of PLRX include TANG CAPITAL MANAGEMENT LLC, Monaco Asset Management SAM, among 8 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.